arrow
A

André Cabié

antilles university and montpellier university and fort-de-france university hospital
H指数:52
被引数:9,138

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long‑Term Effectiveness and Safety of Doravirine‑Based Antiretroviral Regimens in Virologically Suppressed People with HIV: The French Dat’AIDS Cohort

多拉韦林为基础的抗逆转录病毒方案在病毒学抑制的HIV感染者中的长期有效性与安全性:法国Dat’AIDS队列研究

2026-08-190
OAAI
Lenacapavir Use in France: A National, Observational Study (LENAddOn)

LENAddOn研究:法国恩曲卡帕韦的使用情况——一项全国性观察性研究

2026-08-190
OAAI
Infection with Chromobacterium violaceum in the Tropical and Subtropical French Overseas Territories of the Americas and the Indian Ocean: A Case-Series and Review

在热带和亚热带美洲及印度洋法属海外领地的Chromobacterium violaceum感染:一个病例系列和综述

2025-12-010
PRE
Molecular epidemiology identifies the expansion of the DENV2 epidemic lineage from the French Caribbean Islands to French Guiana and mainland France, 2023 to 2024
2024-03-289
OAAI
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial
2024-03-014
OA
Phylogenetic Investigations of Dengue 2019-2021 Outbreak in Guadeloupe and Martinique Caribbean Islands

在瓜德罗普岛和马提尼克岛的登革热2019 2021暴发的系统发育研究

2023-09-205
OAAI
Frailty and prefrailty phenotypes increase the odds of abnormal cognitive impairment screens in people with HIV
AIDS
IF3.1
2023-08-032
PRE
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir

在接受索特罗维单抗或尼马雷韦治疗的轻度至中度Omicron BA.1和BA.2新型冠状病毒肺炎的高危患者中,PCR转换为阴性的时间

2023-04-0113
OA